IntraBio, a U.K. based biopharmaceutical company, has received an Orphan Drug Designation from the US Food and Drug Administration (FDA) for its lead compound (IB1000) for the treatment of spinocerebellar […]
FDA Orphan Drug Designation for Spinocerebellar Read More »
Catch up on the Autumn’s latest research news.
Research News – October and November 2017 Read More »
Ataxia UK is working for the first time with the Spanish ataxia patient group R+SCAs (PLATAFORMA DE APOYO A LA INVESTIGACIÓN DE LAS ATAXIAS ESPINOCEREBELOSAS) in funding a research project
New partnership between Ataxia UK and the Spanish organisations R+SCAs and ACAH Read More »
Read up on the latest research news!
Latest Research News – March and April 2017 Read More »
Read up on the latest research news!
Latest Research News – January and February 2017 Read More »
Read up on the latest research news!
Latest Research News – December 2016 Read More »
the European Commission approves the first 23 European Reference Networks for rare diseases (ERNs), including the one covering the ataxias.
European Reference Networks Read More »
Read up on the latest research news!
Latest Research News – July and August 2016 Read More »
Read up on the latest research news!
Latest research news – May and June 2016 Read More »
